MedTrace Logo

Coagulation Parameters in Postmenopausal Breast Cancer Patients Under Adjuvant Hormonal Therapy

NCT00814034 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 306

Last updated 2015-09-07

No results posted yet for this study

Summary

The objective of the study is to monitor the changes of blood coagulation parameters in postmenopausal patients who are treated with adjuvant Hormonal Therapy for a total of 5 years. The values of the standard coagulation parameters throughout the study will be compared with the baseline values.

Conditions

Sponsors & Collaborators

  • Hellenic Breast Surgeons Society

    lead OTHER

Principal Investigators

  • Christos Markopoulos, MD · Hellenic Breast Surgeons Society

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2009-12-31
Completion
2011-12-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00814034 on ClinicalTrials.gov